Comparable to Pasteur of promise Philippine old to prevail influenza vaccine win vaccine permit

Comparable to Pasteur of promise Philippine old to prevail influenza vaccine win vaccine permit
First type the intersection of influenza and 2009 the intersection of unit price and vaccine permit, become U.S.A. prepare for the intersection of influenza and large prevailing great milestone autumn
Lyons and Swift and Walter of Pennsylvania state of U.S.A. of France, September 15 of 2009 - -Comparable to Philippines - Ann the Wan 's of the promise (code of European stock exchange: SAN, the code of New York stock exchange: SNY) The vaccine Division is comparable to Philippine Pasteur of the promise to announce today under command, company's first type influenza ( H1N1) The supplementary biologicals that 2009 unit price vaccine puts forward permit applying (sBLA) Have already got American food medicines and supervised the administration bureau (FDA) Approval.
Obtain first type influenza ( H1N1) that FDA permits 2009 unit price vaccine is a kind of deactivation influenza vaccine, suitable for the initiative immunity in 6 months or crowd of the above age, in order to prevent the new first type influenza ( H1N1) of great popularity Influenza that 2009 virus causes. Comparable to the first type influenza ( H1N1) of Philippine Pasteur of the promise 2009 unit price vaccine only got U.S.A. to permit, support low to 6 months influenza vaccine that age crowd inoculated.
Comparable to Philippine President CEO Wayne Pisano Pasteur of the promise to say: "First type influenza ( H1N1) Vaccine gets approval of U.S.A. FDA to prepare for great a prevailing key milestone of influenza, it must think the U.S. government offered the vaccine products permitted to make comparable to Philippine Pasteur of the promise, cooperate with great popular immunity its work with all strength. First type influenza ( H1N1) Development and production of vaccine will continue becoming comparable to Philippines - Pasteur's focal point of work of the promise, we produce vaccine of the centralized company speciality and various resources, face the present public health challenge straightly. "
Before this, seeing that FDA proposes to first type influenza ( H1N1) 2009 malicious one of vaccine make a variation and carry on the assessment ' Adopt and supervise the procedure with sanctioning new poisonous one included of vaccine of annual seasonal influenza the samely) ,Comparable to Philippine Pasteur of the promise to put forward and supplement the biologicals to permit applying on August 7.
Comparable to Pasteur, Philippines of promise, pass the clinical experiment ' August 6 is started in U.S.A.) Study its first type influenza ( H1N1) And security that the immunity of 2009 unit price vaccine is original, the final result of the above-mentioned clinical experiment will offer guidance for best dosage, inoculating needle number and immune procedure of vaccine. Meanwhile, are comparable to promise Philippines - Pasteur and cooperate with European Union appropriate authorities closely, to the first type influenza ( H1N1) which France produces Vaccine launches clinical research.
About first type influenza ( H1N1) Antigenic vaccine of 2009 forms
First type influenza ( H1N1) 2009 form antigenic production procedure and three the intersection of price and seasonal the intersection of influenza and vaccine of vaccine ' Have American licences) Production procedure all the same. Vaccine includes first type influenza California 07/2009 (H1N1) V hemagglutinin of virus (HA) 15mcg, the licensed-in products form are single dosage injection west forest bottles or west forest bottles of much dosage. Among them, the single dosage products have not used preservatives, many dosage west forest bottle contains a kind of preservative.
Safe information of vaccine of American market
Know composition seriously irritated to the intersection of egg and albumen, vaccine any, inoculate the intersection of influenza and vaccine any, appear and can't inoculate vaccine of influenza to jeopardize individual whose life reacts before this already. Because Green - syndrome in Bali recurs to have relevance for the moment with the influenza vaccinations, individual with syndrome history of Green - Bali inoculates new first type influenza ( H1N1) 2009 unit price vaccines, must fully weigh the advantage and disadvantages. Inoculate first type influenza ( H1N1) 2009 unit price vaccine must not offer protection to all people.
Comparable to the production of Philippine Pasteur's influenza vaccine of promise
Comparable to the intersection of promise and Philippines - Pasteur in France Wade riel (Val de Reuil) With Swift and Walter of Pennsylvania state of U.S.A. (Swiftwater) There are vaccine production bases of influenza, and all influenza vaccine production facilities pass special design and disposition, production that can vaccine prevails from the production of vaccine of seasonal influenza to prepare for influenza greatly rapidly.
Influenza vaccine 40% supplied in the whole world comes from being comparable to Philippine Pasteur of the promise. In 2008/2009 influenza seasons, it is that U.S.A. supplied over 45% of the influenza vaccine to comparable to Philippine Pasteur of the promise.

|